Legend Biotech’s AGM Highlights Shareholder Confidence
Company Announcements

Legend Biotech’s AGM Highlights Shareholder Confidence

Legend Biotech (LEGN) has released an update.

Legend Biotech Corporation held its annual general meeting on October 21, 2024, where shareholders approved key resolutions, including the re-election of directors and an increase in shares for their 2020 Restricted Shares Plan. The meeting witnessed robust participation with over 95% of shares represented, underscoring strong shareholder engagement. These decisions highlight ongoing confidence in Legend Biotech’s strategic direction.

For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskLegend Biotech Reports Strong Sales Growth in Q3 2024
TheFlyLegend Biotech reports Q3 EPS (34c), consensus (42c)
Austin AngeloIs LEGN a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App